• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

VIDEO: Susan Urba, MD, Discusses Chemotherapy-Induced Nausea and Vomiting

Article

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that treatment-related factors used to stratify patients to prevent chemotherapy-induced nausea and vomiting are the actual chemotherapy drugs.

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that treatment-related factors used to stratify patients to prevent chemotherapy-induced nausea and vomiting are the actual chemotherapy drugs. Dr Urba says that there are specific lists of medications that breakdown the medications into categories, such as highly emetogenic and moderately emetogenic. Dr Urba uses the medication cisplatin as an example of one of the widely used, highly emetogenic treatments used.

This video was taken on November 9 at the NAMCP Fall Managed Care Forum in Las Vegas, NV.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
AHA 2025 recap layered on photo of Bourbon Street in New Orleans | Image credit: SeanPavonePhoto - stock.adobe.com
Screenshot of an interview with Stephen Nicholls, MBBS, PhD
Screenshot of an interview with Roy Mathew, MD
Screenshot of an interview with Vallerie McLaughlin, MD
Oncology experts at PCOC
Susan Cantrell, CEO of AMCP
Michael Hassett, MD, MPH
Khush Kharidia, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.